@CambridgeDay Re: registration, this is only required for studies of investigational drugs/devices not all as implied & registration for publication is not a requirement but a poorly enforced standard. FDA rule here https://t.co/vn8fBomMGk, some data o
RT @JoshuaDWallach: Nice new @BMCMedicine paper by @l_trinquart @adamgdunn @ftbourgeois: 20% published RCTs prospectively registered. http…
RT @JoshuaDWallach: Nice new @BMCMedicine paper by @l_trinquart @adamgdunn @ftbourgeois: 20% published RCTs prospectively registered. http…
RT @JoshuaDWallach: Nice new @BMCMedicine paper by @l_trinquart @adamgdunn @ftbourgeois: 20% published RCTs prospectively registered. http…
RT @JoshuaDWallach: Nice new @BMCMedicine paper by @l_trinquart @adamgdunn @ftbourgeois: 20% published RCTs prospectively registered. http…
RT @JoshuaDWallach: Nice new @BMCMedicine paper by @l_trinquart @adamgdunn @ftbourgeois: 20% published RCTs prospectively registered. http…
RT @JoshuaDWallach: Nice new @BMCMedicine paper by @l_trinquart @adamgdunn @ftbourgeois: 20% published RCTs prospectively registered. http…
Nice new @BMCMedicine paper by @l_trinquart @adamgdunn @ftbourgeois: 20% published RCTs prospectively registered. https://t.co/RuJfVwVFZA. Interesting comparison: @Yale_CRIT paper found more promising rates (77%) among RCTs in specialty society journals h
RT @ChrisW_PharmaG: Trials that were fully or partly funded by industry are less likely to be unregistered or retrospectively registered th…
RT @ChrisW_PharmaG: Industry studies are also MORE likely than non-industry studies to report the outcomes specified in the trial registry…
RT @Majikthyse: Big Pharma critics should take note. https://t.co/BCeLTqsXN5
RT @ChrisW_PharmaG: Industry studies are also MORE likely than non-industry studies to report the outcomes specified in the trial registry…
RT @ChrisW_PharmaG: Industry studies are also MORE likely than non-industry studies to report the outcomes specified in the trial registry…
RT @ChrisW_PharmaG: Industry studies are also MORE likely than non-industry studies to report the outcomes specified in the trial registry…
Big Pharma critics should take note.
RT @ChrisW_PharmaG: Industry studies are also MORE likely than non-industry studies to report the outcomes specified in the trial registry…
RT @ChrisW_PharmaG: Trials that were fully or partly funded by industry are less likely to be unregistered or retrospectively registered th…
RT @ChrisW_PharmaG: Trials that were fully or partly funded by industry are less likely to be unregistered or retrospectively registered th…
RT @ChrisW_PharmaG: Trials that were fully or partly funded by industry are less likely to be unregistered or retrospectively registered th…
RT @YaleSPH: A team of researchers @YaleMed, @YaleSPH, @UAM_Madrid and @nyuschoolofmed examine whether clinical trials that are unregistere…
Industry studies are also MORE likely than non-industry studies to report the outcomes specified in the trial registry (63.9% vs 50.4%), & no more likely to report positive results (65.7% vs 66.8%). Nice to see, even if room for imprvt. #alltrials #pub
Trials that were fully or partly funded by industry are less likely to be unregistered or retrospectively registered than those without industry funding. I calculate that 83.3% of industry studies are prospectively registered vs 59.3% non-industry studies.
RT @YaleSPH: A team of researchers @YaleMed, @YaleSPH, @UAM_Madrid and @nyuschoolofmed examine whether clinical trials that are unregistere…
RT @YaleSPH: A team of researchers @YaleMed, @YaleSPH, @UAM_Madrid and @nyuschoolofmed examine whether clinical trials that are unregistere…
RT @YaleSPH: A team of researchers @YaleMed, @YaleSPH, @UAM_Madrid and @nyuschoolofmed examine whether clinical trials that are unregistere…
A team of researchers @YaleMed, @YaleSPH, @UAM_Madrid and @nyuschoolofmed examine whether clinical trials that are unregistered or registered were more likely to report favorable findings. https://t.co/H0zzNKWMZD @jsross119 @JoshuaDWallach @gregggonsalves
RT @RecheckHealth: Methodology Ethics #EBM all seem to be rare breed nowadays. Depressing and of great concern. #publichealth #evidence htt…
RT: DataSciFact: About 2/3 of clinical trials are pre-registered https://t.co/ukRhxRFTpj
Adherence to the International Committee of Medical Journal Editors’ (ICMJE) prospective registra... https://t.co/4o8ukbavUF #trialsjournal. Il faut changer de bible médicale et c est urgent
Methodology Ethics #EBM all seem to be rare breed nowadays. Depressing and of great concern. #publichealth #evidence
RT @jsross119: High-impact specialty journals not uniformly adhering to #ICMJE clinical trial prospective registration requirements: 10% tr…
RT @DataSciFact: About 2/3 of clinical trials are pre-registered https://t.co/c8swQpbNAd
RT @DataSciFact: About 2/3 of clinical trials are pre-registered https://t.co/c8swQpbNAd
About 2/3 of clinical trials are pre-registered https://t.co/pcE4cb1L5W #datascience #analytics
About 2/3 of clinical trials are pre-registered https://t.co/c8swQpbNAd
Jetzt bin ich mal überrascht.
"Unregistered trials were more likely to report favorable findings than were registered trials" https://t.co/6hV7gsW0yn autism-relevant, free, via @hildabast
God dammit
RT @jsross119: High-impact specialty journals not uniformly adhering to #ICMJE clinical trial prospective registration requirements: 10% tr…
Even among top journals there's much room for improvement. Around a third of trials not registered prospectively https://t.co/Pyl4eC2Tg9
RT @jsross119: High-impact specialty journals not uniformly adhering to #ICMJE clinical trial prospective registration requirements: 10% tr…
"Adherence to the ICMJE’s prospective registration policy remains sub-standard, even in the highest-impact journals associated with US professional medical societies. These journals frequently published unregistered trials and tria…https://t.co/4knjqN2Dya
RT @hildabast: Yikes! A third of the trials in the 10 highest impact US med specialty journals either unregistered or registered retrospect…
RT @MedicalEvidence: Adherence to the ICMJE prospective registration policy & implications for outcome integrity - a cross-sectional analys…
Nephrology Rep not bad (only 2/39 RCTs not registered) Check our full text (free)
RT @hildabast: Yikes! A third of the trials in the 10 highest impact US med specialty journals either unregistered or registered retrospect…
RT @hildabast: Yikes! A third of the trials in the 10 highest impact US med specialty journals either unregistered or registered retrospect…
Yikes! A third of the trials in the 10 highest impact US med specialty journals either unregistered or registered retrospectively. Annals of Neurology is *so* at the bottom of the class! J Clin Oncol & Blood, blemish-free - kudos! https://t.co/thO791Su
RT @jsross119: High-impact specialty journals not uniformly adhering to #ICMJE clinical trial prospective registration requirements: 10% tr…
RT @jsross119: High-impact specialty journals not uniformly adhering to #ICMJE clinical trial prospective registration requirements: 10% tr…
RT @jsross119: High-impact specialty journals not uniformly adhering to #ICMJE clinical trial prospective registration requirements: 10% tr…
J’avoue que je pensais qu’on avait pas le droit de les enregistrer a posteriori
RT @Formindep: Etude Trials: 10% des essais publiés dans 10 revues US n'étaient pas enregistrés. 23% des essais enregistrés l'ont été a pos…
Uh oh. Defeats the purpose!
RT @JoshuaDWallach: CRITical Thinking / @BioMedCentral blog outlines efforts that could "help mitigate the potential negative impact of sub…
RT @Formindep: Etude Trials: 10% des essais publiés dans 10 revues US n'étaient pas enregistrés. 23% des essais enregistrés l'ont été a pos…
RT @jsross119: High-impact specialty journals not uniformly adhering to #ICMJE clinical trial prospective registration requirements: 10% tr…
RT @Formindep: Etude Trials: 10% des essais publiés dans 10 revues US n'étaient pas enregistrés. 23% des essais enregistrés l'ont été a pos…
RT @Formindep: Etude Trials: 10% des essais publiés dans 10 revues US n'étaient pas enregistrés. 23% des essais enregistrés l'ont été a pos…
RT @Formindep: Etude Trials: 10% des essais publiés dans 10 revues US n'étaient pas enregistrés. 23% des essais enregistrés l'ont été a pos…
RT @Formindep: Etude Trials: 10% des essais publiés dans 10 revues US n'étaient pas enregistrés. 23% des essais enregistrés l'ont été a pos…
Adherence to the ICMJE prospective registration policy & implications for outcome integrity - a cross-sectional analysis of trials published in high-impact specialty society journals via #Trialsjournal: https://t.co/Li1aBghOsJ
RT @jsross119: High-impact specialty journals not uniformly adhering to #ICMJE clinical trial prospective registration requirements: 10% tr…
RT @Formindep: Etude Trials: 10% des essais publiés dans 10 revues US n'étaient pas enregistrés. 23% des essais enregistrés l'ont été a pos…
Etude Trials: 10% des essais publiés dans 10 revues US n'étaient pas enregistrés. 23% des essais enregistrés l'ont été a posteriori (68% d'entre eux assez tardivement pour connaître l'issue de l'essai). Les essais non enregistrés étaient plus favorables. h
RT @StuartBuck1: From a couple of our grantees: https://t.co/WNsHVBiFWF
RT @HenkJanOut: De ICMJE policy wordt slecht nagevolgd, ook door de medical journals die zelf die policy ondersteunen. https://t.co/jgD5Bmg…
RT @JoshuaDWallach: CRITical Thinking / @BioMedCentral blog outlines efforts that could "help mitigate the potential negative impact of sub…
RT @Yale_CRIT: New @Yale_CRIT #trialsjournal article & @BioMedCentral blog on #ICMJE clinical trial prospective registration requirements:…
RT @JoshuaDWallach: Prospective registration among trials published in specialty society journals: We can do more to promote transparency a…
CRITical Thinking / @BioMedCentral blog outlines efforts that could "help mitigate the potential negative impact of substandard prospective clinical trial registration." https://t.co/7zMJ98k15C https://t.co/oeGBUD8YeB https://t.co/mMOw2VcxLF
RT @Yale_CRIT: New @Yale_CRIT #trialsjournal article & @BioMedCentral blog on #ICMJE clinical trial prospective registration requirements:…
RT @jsross119: High-impact specialty journals not uniformly adhering to #ICMJE clinical trial prospective registration requirements: 10% tr…
New @Yale_CRIT #trialsjournal article & @BioMedCentral blog on #ICMJE clinical trial prospective registration requirements: Among trials published in 10 highest-impact US med specialty society journals,10% unregistered & unregistered trials more li
RT @jsross119: High-impact specialty journals not uniformly adhering to #ICMJE clinical trial prospective registration requirements: 10% tr…
Prospective registration among trials published in specialty society journals: We can do more to promote transparency and research integrity. New @BioMedCentral blog post for @Yale_CRIT paper out today in #trialsjournal. https://t.co/WgUt1W6EKx https://t
RT @jsross119: High-impact specialty journals not uniformly adhering to #ICMJE clinical trial prospective registration requirements: 10% tr…
From a couple of our grantees:
RT @jsross119: High-impact specialty journals not uniformly adhering to #ICMJE clinical trial prospective registration requirements: 10% tr…
RT @jsross119: High-impact specialty journals not uniformly adhering to #ICMJE clinical trial prospective registration requirements: 10% tr…
High-impact specialty journals not uniformly adhering to #ICMJE clinical trial prospective registration requirements: 10% trials unregistered; 23% registered retrospectively; of these, 68% registered after primary endpoint collection started #trialsjournal